The much-rumored acquisition of major medical point-of-care reference database Epocrates by practice management/EHR leader Athenahealth has many good points for the latter, including the integration of drug interaction alerts into EHRs. Epocrates’ stumbles into mobile EHRs may also have, paradoxically, made it more attractive. But even with this, financial observers see Athenahealth as essentially sideways in terms of growth. But it may point to the major trends of 2013 your Editors have seen for awhile: a push for integration into easier-to-by ‘all in one’ packages; consolidation in order to stay in place in a muddling market. 4 observations about the $293 million athenahealth-Epocrates acquisition (MedCityNews) Editor Donna’s note: An interesting aside, for those who follow palace intrigues and the consolidation of the EHR market, is Allscripts’ ‘Christmas-surprise’ CEO dumping referred to at the end of the article, courtesy of financial analysis website Seeking Alpha.
Sign up for our weekly alerts emails - the easiest way to keep up to date!
Most Recent Comments